Zolpidem induces paradoxical metabolic and vascular changes in a patient with PVS

Brain Injury

Volumn 27, Issue 11, 2013, Pages 1320-1329

  Rodriguez Rojas, Rafael ^a,b   Machado, Calixto ^c   Álvarez, Lázaro ^a   Carballo, Maylen ^a   Estevez, Mario ^c   Perez Nellar, Jesus ^d   Pavon, Nancy ^a   Chinchilla, Mauricio ^d   Carrick, Frederick R ^e   Defina, Philip ^f  

^a CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^b ABDUS SALAM INTERNATIONAL CENTRE FOR THEORETICAL PHYSICS   (Italy)

^c INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

^d Hermanos Ameijeras Hospital   (Cuba)

^e Carrick Institute for Graduate Studies   (United States)

^f International Brain Research Foundation   (United States)

Author keywords

Functional magnetic resonance imaging; Magnetic resonance spectroscopy; Persistent vegetative state; Zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; PLACEBO; ZOLPIDEM;

ADULT; ARTICLE; BASILAR ARTERY; BOLD SIGNAL; BRAIN CELL; BRAIN DAMAGE; BRAIN INJURY; BRAIN METABOLISM; CASE REPORT; CAUDATE NUCLEUS; CEREBROVASCULAR ACCIDENT; CONCENTRATION (PARAMETERS); DRUG EFFECT; FEMALE; FRONTAL CORTEX; HUMAN; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PERSISTENT VEGETATIVE STATE; WAKEFULNESS;

ADULT; FEMALE; GABA-A RECEPTOR AGONISTS; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN; PERSISTENT VEGETATIVE STATE; PYRIDINES; STROKE; TREATMENT OUTCOME; WAKEFULNESS;

EID: 84884185566     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2013.794961     Document Type: Article

References (43)

1. Clauss R, Sathekge M, Nel W. Transient improvement of spinocerebellar ataxia with zolpidem. New England Journal of Medicine 2004;351:511-512
2. Clauss R, Nel W. Drug induced arousal from the permanent vegetative state. NeuroRehabilitation 2006;21:23-28
3. Singh R, McDonald C, Dawson K, Lewis S, Pringle AM, Smith S, Pentland B. Zolpidem in a minimally conscious state. Brain Injury 2008;22:103-106
4. Whyte J, Myers R. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: A preliminary placebo controlled trial. American Journal of Physical Medicine & Rehabilitation 2009;88:410-418
5. Staner C, Joly F, Jacquot N, Vlasova ID, Nehlin M, Lundqvist T, Edenius C, Staner L. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: Polysomnographic study in patients with primary insomnia. Current Medical Research and Opinion 2010;26:1423-1431
6. Clauss RP. Neurotransmitters in coma, vegetative and minimally conscious states, pharmacological interventions. Medical Hypotheses 2010;75:287-290
7. Clauss RP, Van Der Merwe CE, Nel HW. Arousal from a semicomatose state on zolpidem. South African Medical Journal 2001; 91:788-789
8. Clauss RP, Nel WH. Effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO brain SPECT in humans. Arzneimittelforschung 2004;54:641-646
9. Brefel-Courbon Ch, Payoux P, Ory F, Sommet A, Slaoui T, Raboyeau G, Lemesle B, Puel M, Montastruc JL, Demonet JF, et al. Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. Annals of Neurology 2007; 62:102-105
10. Machado C, Estevez M, Perez-Nellar J, Gutierrez J, Rodriguez-Rojas R, Carballo-Barreda M, Chinchilla M, Machado A, Portela L, García-Roca MC. Autonomic, EEG, and behavioural arousal signs in a PVS case after Zolpidem intake. Canadian Journal of Neurological Sciences 2011;38:341-344
11. Nyakale NE, Clauss RP, Nel W, Sathekge M. Clinical and brain SPECT scan response to zolpidem in patients after brain damage. Arzneimittelforschung 2010;60:177-181
12. Hoque R, Chesson AL. Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: Fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. Journal of Clinical Sleep Medicine 2009;5:471-476
13. Coleman MR, Davis MH, Rodd JM, Robson T, Ali A, Owen AM, Pickard JD. Towards the routine use of brain imaging to aid the clinical diagnosis of disorders of consciousness. Brain 2009;132: 2541-2552
14. Ances BM, Leontiev O, Perthen JE, Liang C, Lansing AE, Buxton RB. Regional differences in the coupling of cerebral blood flow and oxygen metabolism changes in response to activation: Implications for BOLD-fMRI. Neuroimage 2008;39:1510-1521
15. Buckner RL, Vincent JL. Unrest at rest: Default activity and spontaneous network correlations. Neuroimage 2007;37: 1091-1096
16. Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: A network analysis of the default mode hypothesis. Proceedings of the National Academy of Sciences 2003;100:253-258
17. Vanhaudenhuyse A, Noirhomme Q, Tshibanda L, Bruno MA, Boveroux P, Schnakers C, Soddu A, Perlbarg V, Ledoux D, Brichant JF, et al. Default network connectivity reflects the level of consciousness in non-communicative braindamaged patients. Brain 2010;133:161-171
18. Tracey I, Wise RG. Pharmacological fMRI: A new tool for drug development in humans. Journal of Pharmacy Practice 2001;14: 368-371
19. Wise RG, Tracey I. The Role of fMRI in drug discovery. Journal of Magnetic Resonance Imaging 2006;23:862-876
20. Lee SK, Kim J, Kim HD, Lee JS, Lee YM. Initial experiences with proton MR spectroscopy in treatment monitoring of mitochondrial encephalopathy. Yonsei Medical Journal 2010;51: 672-675
21. Machado C, Rodriguez R, Carballo M, Perez J, Korein J. Results of proton MRS studies in PVS and MCS patients. Canadian Journal of Neurological Sciences 2009;36:365-369
22. Giacino JT, Kalmar K, Whyte J. The JFK Coma Recovery Scale-Revised: Measurement characteristics and diagnostic utility. Archives of Physical Medicine & Rehabilitation 2004;85: 2020-2029
23. Friston KJ, Mechelli A, Turner R, Price CJ. Nonlinear responses in fMRI: The Balloon Model, volterra kernels, and other hemodynamics. Neuroimage 2000;12:466-477
24. Friston KJ. Bayesian estimation of dynamical systems: An application to fMRI. Neuroimage 2002;16:513-530
25. Machado C, Estévez M, Rodríguez R, Pérez-Nellar J, Chinchilla M, Carrick FR, Leisman G, Melillo R, Gutiérrez J, Carballo M, et al. Zolpidem arousing effect in persistent vegetative state patients. Submitted for publication.
26. Salva P, Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem: Therapeutic implications. Clinical Pharmacokinetics 1995;29:142-153
27. Vlase L, Popa A, Neag M, Muntean D, Baldea I, Leucuta SE. Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers. Journal of Clinical Pharmacology 2010;51: 1233-1236
28. Walusinski O, Deputte B. The phylogeny, ethology and nosology of yawning. Revue Neurologique (Paris) 2004;160:1011-1121
29. Guggisberg A, Mathis J, Herrmann U, Hess C. The functional relationship between yawning and vigilance. Behavioural Brain Research 2007;179:159-166
30. Cattaneo L, Cucurachi L, Chierici E, Pavesi G. Pathological yawning as a presenting symptom of brain stem ischaemia in two patients. Journal of Neurology, Neurosurgery & Psychiatry 2006; 77:98-100
31. Hajek M, Dezortova M. Introduction to clinical in vivo MR spectroscopy. European Journal of Radiology 2008;67:185-193
32. Clark JF, Doepke A, Filosa JA, Wardle RL, Lu A, Meeker TJ, Pyne-Geithman GJ. N-Acetylaspartate as a reservoir for glutamate. Medical Hypotheses 2006;67:506-512
33. Magistretti PJ. Role of glutamate in neuron-glia metabolic coupling. American Journal of Clinical Nutrition 2009;90: 875S-880S.
34. Magistretti PJ. Neuroscience. Low-cost travel in neurons. Science 2009;325:1349-1351
35. Pellerin L, Bouzier-Sore AK, Aubert A, Serres S, Merle M, Costalat R, Magistretti PJ. Activity-dependent regulation of energy metabolism by astrocytes: An update. Glia 2007;55:1251-1262
36. Boly M, Tshibanda L, Noirhomme Q, Vanhaudenhuyse A, Schnakers C, Ledoux D. Functional connectivity in the default network during resting state is preserved in a vegetative but not in a brain dead patient. Human Brain Mapping 2009;30:2393-2400
37. Noirhomme Q, Soddu A, Lehembre R, Vanhaudenhuyse A, Boveroux P, Boly M, Laureys S. Brain connectivity in pathological and pharmacological coma. Frontiers in System Neurosciences 2010
38. Licata SC, Lowen SB, Trksak GH, Maclean RR, Lukas SE. Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation. Progress in Neuropsychopharmacology& Biological Psychiatry 2011;35:1645-1652
39. Prichard J, Rothman D, Novotny E, Petroff O, Kuwabara T, Avison M, Howseman A, Hanstock C, Shulman R. Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proceedings of the National Academy of Sciences USA 1991;88:5829-5831
40. Mangia S, Tka I, Logothetis NK, Gruetter R, Van De Moortele PF, Ugurbil K. Dynamics of lactate concentration and blood oxygen level-dependent effect in the human visual cortex during repeated identical stimuli. Journal of Neuroscience Research 2007;85: 3340-3346
41. Kuwabara T, Watanabe H, Tsuji S, Yuasa T. Lactate rise in the basal ganglia accompanying finger movements: A localized 1H-MRS study. Brain Research 1995;670:326-328
42. Urrila AS, Hakkarainen A, Heikkinen S, Vuori K, Stenberg D, Hakkinen AM. Metabolic imaging of human cognition: An fMRI/ 1H-MRS study of brain lactate response to silent word generation. Journal of Cerebral Blood Flow & Metabolism 2003;23:942-948
43. Mountford CE, Stanwell P, Lin A, Ramadan S, Ross B. Neurospectroscopy: The past, present and future. Chemical Reviews 2010;110:3060-3086